Suchergebnisse - "Kazandjian, Dickran"

PubPharm (95)

71

Clinician Perspectives on Current Issues in Lung Cancer Drug Development

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2016

von Waqar, S. | Bonomi, P. | Govindan, R. | +17

72

Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2016

von Kazandjian, D. | Blumenthal, G. | Luo, L. | +4

73

FDA Approval Summary : Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

enthalten in: The oncologist | 2016

von Kazandjian, D. | Suzman, D. | Blumenthal, G. | +5

CommentIn: Oncologist. 2016 Dec;21(12 ):e3. - PMID 27864576

74

FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2016

von Kazandjian, D. | Blumenthal, G. | Yuan, W. | +3

75

Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy : A Report From the US Food and Drug Administration

enthalten in: JAMA oncology | 2016

von Kazandjian, D. | Khozin, S. | Blumenthal, G. | +7

CommentIn: JAMA Oncol. 2016 Jan;2(1):122. - PMID 26468768

76

FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research | 2016

von Kazandjian, D. | Blumenthal, G. | Yuan, W. | +3

77

A Benefit Risk Analysis Approach To Capture Regulatory Decision-Making: Non-Small Cell Lung Cancer

enthalten in: Clinical pharmacology & therapeutics | 2016

von Raju, G. | Gurumurthi, K. | Domike, R. | +4

78

Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone

enthalten in: Leukemia & lymphoma | 2016

von Manasanch, E. | de Larrea, C. | Zingone, A. | +21

79

A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival

enthalten in: Seminars in oncology | 2016

von Kazandjian, D. | Landgren, O.

80

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

enthalten in: JAMA oncology | 2015

von Korde, N. | Roschewski, M. | Zingone, A. | +36

CommentIn: JAMA Oncol. 2015 Sep;1(6):754-5. - PMID 26181637